Literature DB >> 2420531

Presence of endothelial cell growth factor activity in normal and diabetic eyes.

G A Lutty, C Chandler, A Bennett, C Fait, A Patz.   

Abstract

Two classes of growth factors affecting endothelial cell proliferation have been found previously in ocular tissues: a heat labile mitogen from retina (RDGF) and a heat stable inhibitor of proliferation from vitreous. The relative amounts of these growth factors in normal and diabetic cadaver eyes were investigated using fetal bovine aortic endothelial cell proliferation as an assay. Equivalent levels of RDGF activity were extracted from diabetic and normal sensory retinas. An extract from pigment epithelium and choroid was found to have similar levels of mitogenic activity, but this activity was not as heat labile as RDGF. Like RDGF, equivalent amounts of mitogen were extracted from diabetic and normal tissue. Normal human vitreous inhibited endothelial cell proliferation, and this activity was enhanced by heating the material (10 min., 95 degrees C). Four of the five individual diabetic vitreous samples of identical postmortem times were mitogenic when not heated, and exhibited little or no inhibitory activity when heated. Vitreous of identical postmortem times was pooled and fractionated by heparin-Sepharose chromatography to determine if the heat labile mitogen in vitreous was RDGF. From the insulin-dependent diabetic (IDDM) pooled vitreous sample, a prominent protein of 18 Kd was eluted from the column with 1.2 M NaC1, a characteristic of RDGF. This work suggests that both RDGF and the vitreous inhibitor are found in human vitreous, but their relative concentrations may change in the diabetic state so that retinal neovascularization from retina can occur.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2420531     DOI: 10.3109/02713688608995160

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

1.  Partial characterization of a putative new growth factor present in pathological human vitreous.

Authors:  C Pombo; L Bokser; X Casabiell; J Zugaza; M Capeans; M Salorio; F Casanueva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

2.  Massive proliferation of lens epithelial remnants after Nd-YAG laser capsulotomy.

Authors:  N P Jones; D McLeod; M E Boulton
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

3.  Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy.

Authors:  J Pe'er; R Folberg; A Itin; H Gnessin; I Hemo; E Keshet
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

4.  Biological activities of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes.

Authors:  M Boulton; P Moriarty; Z J Gregor
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

5.  Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy.

Authors:  B Patel; P Hiscott; D Charteris; J Mather; D McLeod; M Boulton
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.